PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6817774

Correlation between Ig-synthesis patterns and lymphoma classification.

A C Hannam-Harris·J Gordon·D H Wright·J L Smith
View original source ↗Export metadata ↓

Abstract

This study examines the link between free immunoglobulin (Ig) light-chain (LC) secretion and the developmental stage of the neoplastic B-cell of origin in B-cell lymphomas. The Kiel developmental scheme for lymphoma classification has been used to define the tumour-cell populations. Twenty-four B-cell lymphomas have been studied. In the small-lymphocytic lymphoma group, secreted Ig consisted of LC exclusively or in excess over heavy-chain (HC). Lymphomas of follicular-centre-cell origin, considered to be from cells further along the normal B-cell differentiation pathway, can be divided into centroblasts or centrocytes according to their histological appearance in tissue sections. Centroblastic lymphomas exhibited strong surface IgM or IgG expression, and the secretion of whole Ig was higher than by cells from the small-lymphocytic lymphomas. Synthesis of HC and LC was balanced in these cultures, both intracellularly and in secreted material. The centrocytic lymphomas comprised a functionally more heterogeneous group, the SIg varied in intensity and was of surface IgM, D or G. Likewise Ig synthesis was variable in quantity and composition, some cases secreting LC exclusively while others, including the cases expressing SIgG, secreted balanced HC and LC. In the Kiel classification centrocytes are considered to be more mature than centroblasts. Our data suggest that centrocytic lymphomas are heterogeneous in origin, some preceding and others following centroblasts in the B-cell maturation sequence. These data are discussed in relation to current concepts of B-cell maturation and lymphoma histology.

Explore related subjects

B-LymphocytesCells, CulturedElectrophoresis, Polyacrylamide GelHumansImmunoglobulin DImmunoglobulin GImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsImmunoglobulin MImmunoglobulinsLymphomaReceptors, Antigen, B-CellComparative StudyJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A C Hannam-Harris, J Gordon, D H Wright, J L Smith. 1982. Correlation between Ig-synthesis patterns and lymphoma classification.. https://doi.org/10.1038/bjc.1982.180

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

Regulation of nucleoside transport by lipopolysaccharide, phorbol esters, and tumor necrosis factor-alpha in human B-lymphocytes.

Nucleoside transport systems and their regulation in human B-lymphocytes have been characterized using the cell lines Raji and Bare lymphoma syndrome-1 (BLS-1) as experimental models. These cells express at least three different nucleoside transport systems as follows: a nitrobenzylthioinosine-sensitive equilibrative transport system of the es-type, which appears to be associated with hENT1 expression, and two Na+-dependent transport systems that may correspond to N1 and to the recently characterized N5-type, which is nitrobenzylthioinosine-sensitive and guanosine-preferring. B cell activators such as phorbol 12-myristate 13-acetate and lipopolysaccharide (LPS) up-regulate both concentrative transport systems but down-regulate the equilibrative es-type transporter, which correlates with lower hENT1 mRNA levels. These effects are dependent on protein kinase C activity. Phorbol 12-myristate 13-acetate and LPS also induce an increase in tumor necrosis factor-alpha (TNF-alpha) mRNA levels, which suggest that this cytokine may mediate some of the effects triggered by these agents, since addition of TNF-alpha alone can increase N1 and N5 transport activities by a mechanism that also depends on protein kinase C activation. Interestingly, TNF-alpha down-regulates es activity, but this effect cannot be abolished by inhibiting protein kinase C. This study reveals differential regulation of nucleoside transport systems following activation of human B-lymphocyte cell lines by agents of physiological relevance such as TNF-alpha and LPS. Moreover, it indicates that the recently characterized N5 transport system can also be regulated following B cell activation, which may be relevant to lymphocyte physiology and to the treatment of lymphocyte malignancies.

B-Lymphocytes↗
PubMed1998

Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3' enhancer.

Maf family transcription factors are important regulators in various differentiation systems. Putative Maf recognition elements (MAREs) are found in the 3' enhancer region of the immunoglobulin heavy chain (IgH) gene. These elements are bound in B-cell extracts by a heterodimeric protein complex containing both Bach2 and a small Maf protein. Analysis of normal hematopoietic cells revealed that Bach2 is specifically expressed in B cells. Bach2 is abundantly expressed in the early stages of B-cell differentiation and turned off in terminally differentiated cells. Bach2 acts together with MafK as a negative effector of the IgH 3' enhancer and binds to the co-repressor SMRT (silencing mediator of retinoid and thyroid receptor). Hence the Bach2-small-Maf heterodimer may represent the first example of a B-cell lineage, and of a developmental stage-restricted negative effector of the MARE in the IgH 3' enhancer region.

B-Lymphocytes↗
PubMed1998

BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci.

The molecular mechanism involved in the process of antigen-driven somatic hypermutation of Ig genes is unknown, but it is commonly believed that this mechanism is restricted to the Ig loci. B cell lymphomas commonly display multiple somatic mutations clustering in the 5'-regulatory region of BCL-6, a proto-oncogene encoding for a POZ/Zinc finger transcriptional repressor expressed in germinal center (GC) B cells and required for GC formation. To determine whether BCL-6 mutations represent a tumor-associated phenomenon or reflect a physiologic mechanism, we screened single human tonsillar GC B cells for mutations occurring in the BCL-6 5'-noncoding region and in the Ig variable heavy chain sequences. Thirty percent of GC B cells, but not naive B cells, displayed mutations in the 742 bp region analyzed within the first intron of BCL-6 (overall frequency: 5 x 10(-4)/bp). Accordingly, an expanded survey in lymphoid malignancies showed that BCL-6 mutations are restricted to B cell tumors displaying GC or post-GC phenotype and carrying mutated Ig variable heavy chain sequences. These results indicate that the somatic hypermutation mechanism active in GC B cells physiologically targets non-Ig sequences.

B-Lymphocytes↗